Company intelligence
Advarra
We're making the protocol lifecycle intelligent.
About Advarra
Advarra provides the platform, insights, and expertise that make clinical trials more efficient and connected. As the leading independent IRB, we bring more than 40 years of trusted oversight to the industry, setting the standard for ethical reviews while building the largest collection of digitized protocols and operational data. This combined intelligence guides the protocol’s entire journey—from design through review, activation, and conduct—fueling a smarter, more adaptive research ecosystem. Backed by decades of partnership with research sites, Advarra delivers the core systems and services that 50,000 investigators and their study teams depend on for optimal trial operations. Integrated with our solutions for study design, startup, and conduct, these capabilities create a collaborative technology platform trusted by sponsors and CROs globally. By designing AI-powered workflows that streamline operations, reduce administrative burden, and promote transparency for all study stakeholders, we’re reimagining what’s possible in clinical research.
Verified activity
Signals from Advarra
12 published signals
Research & Knowledge
Advarra published a trend report analyzing protocol amendments across over 30,000 clinical studies to help study teams design future studies.
Reported by Austin Weaver
Presence & Recognition
Advarra CEO Gadi Saarony shared four opportunities to strengthen clinical research in the U.S. during the ENRICH-CT session hosted by the Milken Institute.
Reported by Advarra
Research & Knowledge
Advarra published a trend report analyzing protocol amendments across over 30,000 clinical studies to help study teams design future studies.
Reported by Bryan Jobe
Research & Knowledge
Advarra analyzed 30,000+ studies to surface avoidable therapeutic-area-level trends for the research community.
Reported by Anna Hrovat-Staedter
Products & Services
Advarra built Advarra Study Collaboration to help clinical teams track study progress more connected and less dependent on manual follow-ups.
Reported by Christian Avelar
Research & Knowledge
Advarra published a trend report analyzing protocol amendments across over 30,000 clinical studies to help study teams design future studies.
Reported by Mike Pallagi
Research & Knowledge
Advarra published a blog post by James Riddle explaining how the NIH Guidelines define recombinant and synthetic nucleic acids, including direct clarification from the NIH Office of Science Policy.
Reported by Drew Moffat
Research & Knowledge
Advarra published a trend report titled
Reported by Advarra
Research & Knowledge
Advarra published a trend report examining how protocols evolve over time, operational challenges across TAs, and historical amendment patterns to inform future study design.
Reported by Advarra
People
Advarra employee Rachel Garrett has worked across an IRB, CRO, and university research site.
Reported by Tyler Dougherty
People
Advarra employee Rachel Garrett has worked across an IRB, CRO, and university research site.
Reported by Gregory Yudin
Presence & Recognition
Advarra team will attend the Partnerships with Sites Summit hosted by Mike Eckrote at 4:45 PM for Smarter Site Collaboration Through Connected Technology.
Reported by Paul Kelly